type-2

Documents about type-2

• GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#154871ClinicalTrials.gov
• A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes#158191ClinicalTrials.gov
• Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)#160263ClinicalTrials.gov
• The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy#162428ClinicalTrials.gov
• A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy#172534ClinicalTrials.gov
• Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes#180325ClinicalTrials.gov
• Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens#180336ClinicalTrials.gov
• Control:Diabetes Pilot Study I#127757ClinicalTrials.gov
• True to a Type, Vol. 1 (of 2)#50014Project Gutenberg
• Regulatory Request NIS in Korea#127838ClinicalTrials.gov
• Sugar Challenge Study#136299ClinicalTrials.gov
• GALLANT 7 Tesaglitazar Add-on to Sulphonylurea#143761ClinicalTrials.gov
• Evaluation of Type 2 Diabetes Treatment#146371ClinicalTrials.gov
• forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)#172538ClinicalTrials.gov
• Do insomnia and physical activity mediate the relationship between diabetes and depression in people with type 2 diabetes?#5308Europe PMC
• Commentary on “Are Individuals With Type 2 Diabetes Metabolically Inflexible? A Systematic Review and Meta‐Analysis”#27544HAL (France)
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes#121263ClinicalTrials.gov
• To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea Monotherapy#123631ClinicalTrials.gov
• Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing#127756ClinicalTrials.gov
• Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease#127813ClinicalTrials.gov
• Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease#136266ClinicalTrials.gov
• A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus#136282ClinicalTrials.gov
• Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients#136300ClinicalTrials.gov
• The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes#141198ClinicalTrials.gov
• TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.#143804ClinicalTrials.gov
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight#154883ClinicalTrials.gov
• Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus#146343ClinicalTrials.gov
• Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2#158139ClinicalTrials.gov
• Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin#18526ClinicalTrials.gov
• The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus#28578ClinicalTrials.gov
• A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)#121284ClinicalTrials.gov
• A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes#154888ClinicalTrials.gov
• A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.#158124ClinicalTrials.gov
• Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents#175058ClinicalTrials.gov
• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control#175074ClinicalTrials.gov
• The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes#180362ClinicalTrials.gov
• Phosphodiesterase Type 5 Inhibitors in Patients With Group 2 Pulmonary Hypertension#148641ClinicalTrials.gov
• To Evaluate the Response to Glucagon During Hypoglycemia#67816ClinicalTrials.gov
• Add Glucokinase Activator to Target A1c#121271ClinicalTrials.gov
• Weight Loss Clinical Decision Support#136230ClinicalTrials.gov
• The Acute Effect of Interval-walking#141190ClinicalTrials.gov
• Glycemia in Diabetic Elders Trial#143785ClinicalTrials.gov
• Empa PASS on Urinary Tract Malignancies#146344ClinicalTrials.gov
• Korean Post-marketing Surveillance for Kombiglyze XR®#152384ClinicalTrials.gov
• Prognosis of Type 2 Diabetic Patients#181688ClinicalTrials.gov
• Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysis.#148094NCBI PubMed Central
• Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)#160299ClinicalTrials.gov
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control#28577ClinicalTrials.gov
• Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes#123634ClinicalTrials.gov
• Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)#127726ClinicalTrials.gov